Effect of captopril on heavy proteinuria in azotemic diabetics.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  New England Journal of Medicine

• Publication date

  1985-12-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM198512263132601PMID 3906398
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Renin Secretion in Advanced Diabetic Nephropathy.

  1984cited by this paper
• Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.

  1983cited by this paper
• Effect of dipyridamole on proteinuria of diabetic nephropathy.

  1983cited by this paper
• The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies.

  1982cited by this paper
• Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension.

  1980cited by this paper
• Hyporeninemic Hypoaldosteronism in Diabetes Mellitus: Studies of the Autonomic Nervous System's Control of Renin Release

  1979cited by this paper
• Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes.

  1979cited by this paper
• Mechanism of angiotensin II-induced proteinuria in the rat.

  1977cited by this paper
• Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus.

  1977cited by this paper
• Plasma Renin Activity and Hypertension in Diabetes Mellitus

  1976cited by this paper

• Lubiprostone in chronic kidney disease: Insights into mitochondrial function and polyamines from a randomized phase 2 clinical trial

  2025cites this paper
• The impact of combined trajectories of serum uric acid, renal function, and blood pressure on long-term survival in patients with chronic kidney disease.

  2025cites this paper
• The association between bone density of lumbar spines and different daily protein intake in different renal function

  2024cites this paper
• [State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review].

  2023cites this paper
• Should we enlarge the indication for kidney biopsy in diabetics? The con part

  2023cites this paper
• New Approaches to Diabetic Nephropathy from Bed to Bench

  2022cites this paper
• Nephrology in Japan

  2021cites this paper
• Blockierung des Renin-Angiotensin-Aldosteron-Systems

  2021cites this paper
• Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study

  2021cites this paper
• Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?

  2020cites this paper
• CKD: Diagnostic and Other Clinical Needs

  2018cites this paper
• Novel avenues for drug discovery in diabetic kidney disease

  2018cites this paper
• 24 Blood Pressure Control in Patients with Glomerulonephritis

  2017cites this paper
• Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease

  2017influential citation
• Mechanobiology and the Kidney Glomerulus

  2016cites this paper
• Role of renin–angiotensin system inhibitors in retardation of progression of end-stage renal failure: a retrospective study

  2016cites this paper
• Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology

  2015cites this paper
• Physical exercise and renal function

  2015cites this paper
• Arteriovenous fistula as a nephroprotective intervention in advanced CKD: scientific discovery and explanation, and the evaluation of interventions.

  2015cites this paper
• Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension

  2014cites this paper
• Novel effective drugs for diabetic kidney disease? or not?

  2014cites this paper
• Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes

  2014cites this paper
• Los inhibidores de la enzima conversora de angiotensina

  2014cites this paper
• perspective Blockade of the renin-angiotensin system for renal future perspectives protection: from history to future

  2013cites this paper
• Oxidative Stress/Angiotensinogen/Renin-Angiotensin System Axis in Patients with Diabetic Nephropathy

  2013cites this paper
• Capítulo XIII

  2013cites this paper
• DRUG SELECTION PERSPECTIVES

  2013cites this paper
• An Overview of Diabetic Nephropathy

  2012cites this paper
• Reactive Oxygen Species in the Pathogenesis of Chronic Kidney Disease: Lessons Derived from Diabetic Nephropathy 118

  2012cites this paper
• Antioxidants in Kidney Diseases: The Impact of Bardoxolone Methyl

  2012cites this paper
• CAPÍTULO XIII COMPLICACIONES MICROVASCULARES DE LA DIABETES.

  2012cites this paper
• Angiotensin-Converting Enzyme Inhibitors in Chronic Renal Failure

  2012cites this paper
• Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes.

  2012cites this paper
• Aspects of the Role of Intraglomerular Pressure as a Cause of Progressive Renal Damage

  2012cites this paper
• Systems biology of kidney diseases.

  2012cites this paper
• The Development and Progression of Chronic Renal Disease

  2012cites this paper
• Swiss Hypertension Treatment Programme with Verapamil and/or Enalapril in Diabetic Patients

  2012cites this paper
• Comparative Cardiovascular Effects of Drugs Used for Hypertension

  2012cites this paper
• CHAPTER 34 – Diabetic nephropathy

  2012cites this paper
• INHIBITION OF RENNIN(cid:26)ANGIOTENSIN(cid:26)ALDOSTERONE SYSTEM AND NEPHROPROTECTION

  2012cites this paper
• Microalbuminuria breakthrough under chronic renin–angiotensin–aldosterone system suppression

  2012cites this paper
• Effects of Enalapril on Renal Parameters in Patients with Primary Glomerulopathies Associated with Chronic Renal Failure

  2012cites this paper
• Angiotensin‐Converting Enzyme Inhibitors

  2011cites this paper
• Safety and Efficacy of Imidapril in the Treatment of Essential Hypertension

  2011cites this paper
• Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

  2011cites this paper
• On the Need to Reissue Renin-Angiotensin-Aldosterone System Suppression in Chronic Kidney Disease

  2011cites this paper
• Blood Pressure Control in Patients with Glomerulonephritis

  2011cites this paper
• Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.

  2011cites this paper
• Clinical practice. Stage IV chronic kidney disease.

  2010cites this paper
• Effect of Efonidipine on Proteinuria in Patients with Chronic Kidney Disease Receiving RAS Blockade

  2010cites this paper
• The RAAS in the pathogenesis and treatment of diabetic nephropathy

  2010cites this paper
• Oxidative stress in diabetic nephropathy.

  2010cites this paper
• Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells

  2010cites this paper
• Protective effect of a poly-phytocompound on early stage nephropathy secondary to experimentally-induced diabetes.

  2010cites this paper
• Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison

  2009cites this paper
• High ambient glucose induces angiotensin-independent AT-1 receptor activation, leading to increases in proliferation and extracellular matrix accumulation in MES-13 mesangial cells.

  2009cites this paper
• Transition of Nephrotic Syndrome

  2009cites this paper
• Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake.

  2009cites this paper
• Renin-Angiotensin-Aldosterone System Blockade in Diabetes: Role of Direct Renin Inhibitors

  2009cites this paper
• Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists

  2009cites this paper
• Long-term renal prognosis of IgA nephropathy with therapeutic trend shifts.

  2009cites this paper
• CHAPTER 88 – Role of Glomerular Pressure in Progression

  2008cites this paper
• Twelve shifting paradigms in diabetic renal disease and hypertension.

  2008cites this paper
• Diabetic Nephropathy

  2008cites this paper
• Collaboration of General Physicians and Nephrologists in the Practice of Renal Failure

  2008cites this paper
• Targeting proteinuria as a valid surrogate for individualized kidney protective therapy.

  2008cites this paper
• Targeting proteinuria as a valid surrogate for individualized kidney protective therapy

  2008cites this paper
• PUK2 LONGITUDINAL DECLINE OF RENAL FUNCTION IN HYPERTENSIVE VETERANS

  2008cites this paper
• 特集: 糖尿病性腎症―糖尿病性腎症治療におけるRAS阻害薬の新展開

  2007cites this paper
• EARLY DIABETIC NEPHROPATHY

  2007cites this paper
• Supratherapeutic Doses of Angiotensin Receptor Blockers to Decrease Proteinuria in Patients with Chronic Kidney Disease

  2007cites this paper
• Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.

  2007cites this paper
• Blockade of the renin-angiotensin system for renal future perspectives protection: from history to future perspective

  2007cites this paper
• Renin Academy in Focus

  2007cites this paper
• Effects of Monotherapy of Temocapril or Candesartan with Dose Increments or Combination Therapy with Both Drugs on the Suppression of Diabetic Nephropathy

  2007cites this paper
• Chronic Treatment with Calcium Channel or Angiotensin Converting Enzyme Inhibitors Renal Function in Streptozotocin-Treated Hypertensive Diabetic Rats

  2006cites this paper
• Losartan: lessons learned from the RENAAL study

  2006cites this paper
• Comparison of captopril and enalapril in the treatment of hypertension in patients with non-insulin dependent diabetes mellitus and nephropathy

  2006cites this paper
• Aldosterone Blockage in Proliferative Glomerulonephritis Prevents Not Only Fibrosis, but Proliferation as Well

  2006cites this paper
• Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?

  2006cites this paper
• Diabetic nephropathy.

  2005cites this paper
• Preventing end stage renal disease in diabetic patients — genetic aspect (part I)

  2005cites this paper
• Angiotensin converting enzyme inhibitors in the treatment of hypertension: Efficacy, metabolic effects and side effects

  2005cites this paper
• Emerging drugs for diabetic nephropathy

  2005cites this paper
• Renal effects of angiotensin converting enzyme inhibitors: Nondiabetic chronic renal disease

  2005cites this paper
• Staff Conference The Pathogenesis and Prevention of Diabetic Nephropathy

  2005cites this paper
• Choosing Initial Therapy for Hypertension

  2005cites this paper
• Diabetic Nephropathy: The Proteinuria Hypothesis

  2005cites this paper
• Therapeutic measures in proteinuric nephropathy.

  2005cites this paper
• Antihypertensive drugs and the kidney

  2004cites this paper
• Aldosterone in the development and progression of renal injury.

  2004cites this paper
• Possible Role of VEGF in the Progression of Kidney Disease in Streptozotocin (STZ)-induced Diabetic Rats: Effects of an ACE Inhibitor and an Angiotensin II Receptor Antagonist

  2004cites this paper
• Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril

  2004cites this paper
• Effects of captopril on diabetic nephropathy in hypertensive women

  2004cites this paper
• Diabetes, Dietary Protein and Glomerular Hyperfiltration

  2004cites this paper
• Relationship between blood glucose control, pathogenesis and progression of diabetic nephropathy.

  2004cites this paper
• Hypertension management in patients with diabetic nephropathy

  2004cites this paper
• Angiotensin converting enzyme inhibition reduces proteinuria in Nigerians with chronic renal disease

  2004cites this paper
• Type I glycogen storage disease: Kidney involvement, pathogenesis and its treatment

  2004cites this paper
• Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.

  2004cites this paper